Biotage AB (publ) reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was SEK 409 million compared to SEK 395 million a year ago. Net income was SEK 34 million compared to SEK 57 million a year ago. Basic earnings per share from continuing operations was SEK 0.49 compared to SEK 0.87 a year ago. Diluted earnings per share from continuing operations was SEK 0.49 compared to SEK 0.87 a year ago.
For the six months, sales was SEK 769 million compared to SEK 781 million a year ago. Net income was SEK 77 million compared to SEK 129 million a year ago. Basic earnings per share from continuing operations was SEK 1.13 compared to SEK 1.95 a year ago. Diluted earnings per share from continuing operations was SEK 1.13 compared to SEK 1.95 a year ago.